Mumbai: Hyderabad-based GVK Biosciences has tied up with Excel PharmaStudies (Excel), a Chinese clinical research organisation (CRO), to conduct
clinical trials in Asia. Under the arrangement, GVK Bio and Excel will help sponsors conduct and manage Phase II-IV of clinical trials, statistical analysis and medical writing.
GVK Bio president Manni Kantipudi said: “This is a first of a kind alliance between an Indian CRO and a Chinese CRO. The GVK Bio-Excel alliance integrates trial management across India and China and provides sponsors with a single point of contact.”
Any India trial for Excel will be carried out by the GVK Bio clinical research team and will be managed by a core project management team of Excel. Similarly, a GVK Bio China trial will be carried out by the Excel team and managed by GVK Bio project management team. Excel PharmaStudies CEO William Xiong said: “It is an important step for Excel and our clients to be able to provide full services in both the important countries.”
The alliance provides clinical trial sponsors access to scientific skills, talent pool, flexible resourcing and cost-effectiveness in both India and China. India has sponsor-friendly regulations and strength in phase two and three clinical trials, while China enjoys advantages in phase three trials and phase four studies.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment